Plain-English translation of NCT07100119 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage trial testing a new medication called that is injected directly into the fluid surrounding your spinal cord. Researchers want to understand how well your body tolerates this medication, what side effects might occur, and how your body processes it. This is one of the first studies of this treatment in people with ALS.
ALS is a serious disease that affects nerve cells controlling muscles. Doctors need new treatment options to help slow or stop the progression of ALS. By testing this medication in small groups at increasing doses, researchers hope to find a safe and effective approach that could eventually help people with this condition.
You likely qualify if…
You likely don't qualify if…
You would receive spinal injections of either the study medication or a placebo (inactive substance) at increasing doses over several visits. Researchers will take blood samples to measure how much medication enters your bloodstream and how quickly your body processes it. You will be monitored closely for any side effects or problems to determine if this treatment is safe and well-tolerated.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Belgium
Canada